Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 2
2005 5
2006 2
2007 1
2008 2
2009 6
2010 3
2011 3
2012 7
2013 4
2014 5
2015 4
2016 2
2017 1
2018 2
2019 4
2020 3
2021 2
2022 2
2023 3
2024 5
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Special Issue: Nanobody.
Chames P, Rothbauer U. Chames P, et al. Antibodies (Basel). 2020 Mar 6;9(1):6. doi: 10.3390/antib9010006. Antibodies (Basel). 2020. PMID: 32155903 Free PMC article.
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.
Oosterlaken M, Rogliardo A, Lipina T, Lafon PA, Tsitokana ME, Keck M, Cahuzac H, Prieu-Sérandon P, Diem S, Derieux C, Camberlin C, Lafont C, Meyer D, Chames P, Vandermoere F, Marin P, Prézeau L, Servent D, Salahpour A, Ramsey AJ, Bécamel C, Pin JP, Kniazeff J, Rondard P. Oosterlaken M, et al. Among authors: chames p. Nature. 2025 Sep;645(8079):262-270. doi: 10.1038/s41586-025-09265-8. Epub 2025 Jul 23. Nature. 2025. PMID: 40702184 Free PMC article.
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
Tapia-Galisteo A, Sánchez-Rodríguez I, Narbona J, Iglesias-Hernández P, Aragón-García S, Jiménez-Reinoso A, Compte M, Khan S, Tsuda T, Chames P, Lacadena J, Álvarez-Vallina L, Sanz L. Tapia-Galisteo A, et al. Among authors: chames p. Oncoimmunology. 2024 Apr 13;13(1):2338558. doi: 10.1080/2162402X.2024.2338558. eCollection 2024. Oncoimmunology. 2024. PMID: 38623463 Free PMC article.
Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity.
González C, Chames P, Kerfelec B, Baty D, Robert P, Limozin L. González C, et al. Among authors: chames p. Biophys J. 2019 Apr 23;116(8):1516-1526. doi: 10.1016/j.bpj.2019.03.012. Epub 2019 Mar 23. Biophys J. 2019. PMID: 30979550 Free PMC article.
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L. Tapia-Galisteo A, et al. Among authors: chames p. Oncoimmunology. 2022 Feb 7;11(1):2034355. doi: 10.1080/2162402X.2022.2034355. eCollection 2022. Oncoimmunology. 2022. PMID: 35154908 Free PMC article.
74 results